Authors


Humcha Hariprakasha

Latest:

Regulatory Considerations for Controlling Intermediates in Type-II Drug Master Files for the Manufacture of Generic Drug Substances

The authors present analysis of the state of control of intermediate identity and quality, based on analysis of recently submitted DMFs.


Brian T. Connell

Latest:

Regulatory Considerations for Controlling Intermediates in Type-II Drug Master Files for the Manufacture of Generic Drug Substances

The authors present analysis of the state of control of intermediate identity and quality, based on analysis of recently submitted DMFs.


Huyi Zhang

Latest:

Appendix: Common Deficiencies Related to Solution NMR in the Type-II DMFs

Appendix to Characterization of Small-Molecule Drug Substances in Type II DMFs Supporting ANDAs, Part I: Solution Nuclear Magnetic Resonance Spectroscopy


Deborah F. Johnson

Latest:

Regulatory Considerations for Controlling Intermediates in Type-II Drug Master Files for the Manufacture of Generic Drug Substances

The authors present analysis of the state of control of intermediate identity and quality, based on analysis of recently submitted DMFs.


Jerry Sellors

Latest:

FT-IR Identification: the Expertise Required To Ensure Compliance

By providing an information "fingerprint", infrared red spectroscopy is a useful tool for identifying counterfeit pharmaceuticals. The authors identify best practices for ensuring compliance.


Olindo Lazzaro

Latest:

Choosing Containment Strategies For Highly Potent APIs

Safe handling of HPAPIs requires determining exposure potential and selecting appropriate containment strategies.


Mark Dalziel

Latest:

Contamination: Invisible And Airborne

Millions of pounds worth of products are at risk if contamination occurs in a cleanroom environment. According to an independent consultant (Cleanroom Management Associates Inc) for our company, contamination from personnel and equipment, such as wheeled carts and tanks, is a major concern in cleanrooms and controlled environments.


Chris Freeman

Latest:

Best Practice: Testing Softgel Capsules

Texture analyzers can be used to evaluate wall hardness and elasticity of softgel capsules.


Claire Freeman, PhD

Latest:

Best Practice: Testing Softgel Capsules

Texture analyzers can be used to evaluate wall hardness and elasticity of softgel capsules.


Mahmoud Hamada

Latest:

Testing the Integrity of Lyophilized Product Containers

Non-destructive container closure integrity testing allows 100% inspection of all ampoules, syringes, vials, and cartridges.


Derek Duncan

Latest:

Updates on Container Closure Integrity Testing for Sterile Injectables

Changes in CCIT testing have followed the evolution of regulatory guidance, and this article examines different possible CCIT strategy approaches.


Robin Hooker

Latest:

Specimen Logistics: The Rx for a Better Dx

Using best practices in specimen preparation, packaging, and shipping can improve efficiency for diagnostic laboratories.


Anthony Serracino Inglott

Latest:

Concept Design for Establishing an Eco-Friendly Pharmaceutical Production Facility in Malta

The authors discuss the concept design of a versatile, sustainable, small-scale facility in Malta that conforms to the European Union’s current good manufacturing practices.


Frederick Schembri

Latest:

Concept Design for Establishing an Eco-Friendly Pharmaceutical Production Facility in Malta

The authors discuss the concept design of a versatile, sustainable, small-scale facility in Malta that conforms to the European Union’s current good manufacturing practices.


Lilian M. Azzopardi

Latest:

Concept Design for Establishing an Eco-Friendly Pharmaceutical Production Facility in Malta

The authors discuss the concept design of a versatile, sustainable, small-scale facility in Malta that conforms to the European Union’s current good manufacturing practices.


Maria Mercieca

Latest:

Concept Design for Establishing an Eco-Friendly Pharmaceutical Production Facility in Malta

The authors discuss the concept design of a versatile, sustainable, small-scale facility in Malta that conforms to the European Union’s current good manufacturing practices.


Anil Kumar Busimi

Latest:

Best Practice: Choosing Glass Or Polymer For Parenteral Packaging

Consider the 3 Ps (product, process, and patient) when choosing a parenteral packaging material.



Hans de Waard

Latest:

Controlled Crystallization During Freeze-Drying

The authors discuss the preparation of lipophilic drug nanocrystals by controlled crystallization during freeze-drying.



Richard Creekmore

Latest:

Early Development GMPs for Drug-Product Manufacturing of Small Molecules: An Industry Perspective (Part III)

IQ Consortium representatives explore industry approaches and practices for applying GMPs in early development.


Caroline Hroncich

Latest:

Public Health Organizations Pen Letter to House and Senate Committees

Nine public health organizations submitted a letter to US House and Senate committees citing concerns about Section 11 of the FDA and NIH Workforce Authorities Modernization Act.


Caroline Hroncich

Latest:

New Lab Instruments Tackle Workflow Challenges

A sampling of new laboratory equipment showcases streamlined operations.


Thomas Baxter

Latest:

Addressing Segregation of a Low-Dosage Direct Blend

The authors modified equipment and the manufacturing process to re-establish content uniformity among tablets.


Partho Bhattacharya

Latest:

Futureproofing the Pharmaceutical Industry through Technology

By focusing on laying strong technology foundations, pharmaceutical businesses can make informed decisions, equip themselves with the capabilities to eliminate threats, and future-proof operations.



Natalia Belikova

Latest:

Determination of Sodium Chloride in Yeast Extract by Ion Chromatography

Determination of sodium chloride level is critical for assessment of purity of yeast extracts. This case study demonstrates the validation of an ion chromatography method as a suitable analytical approach.